Skip to main content
Anthony Heaney, MD, Endocrinology, Los Angeles, CA

AnthonyPHeaneyMD

Endocrinology Los Angeles, CA

Pituitary Disorders & Neuroendocrinology

Associate Professor, Medicine, University of California Los Angeles David Geffen SOM

Dr. Heaney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Heaney's full profile

Already have an account?

  • Office

    200 Med Plz
    Ste 530
    Los Angeles, CA 90095
    Phone+1 310-825-7922
    Fax+1 310-267-1899

Education & Training

  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2001
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
  • Queen's University of Belfast COM
    Queen's University of Belfast COMClass of 1987
  • Queen�s Universtity of Belfast
    Queen�s Universtity of BelfastB.Sc., Biochemistry, with Honors, 1981 - 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Best Doctors in America 2009
  • HypoCCS Award Eli Lilly, 2005
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016  
    McCormack A, Dekkers OM, Petersenn S, Popovic V, Trouillas J, Raverot G, Burman P; ESE survey collaborators (Heaney AP), Eur J Endocrinol, 1/1/2018
  • Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial  
    Lacroix A, Gu F, Gallardo W, Pivonello R, Yu Y, Witek P, Boscaro M, Salvatori R, Yamada M, Tauchmanova L, Roughton M, Ravichandran S, Petersenn S, Biller BMK, Newell-P..., Lancet Diabetes Endocrinol, 1/1/2018
  • Corticotrophic pituitary carcinoma with cervical metasteses; Case report and literature review  
    Yoo F,Kuan EC, Heaney AP, Bergsneider M, Wang MB, Pituitary, 1/1/2018
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Thyroid Ultrasound Screening in Patients with Acromegaly.
    Lai B, Garg D, Heaney AP, Bergsneider M, Leung A, ATA, 1/1/2018
  • Development of a Long-term Hormone-secreting Human Pituitary Tumor in Vitro Model.
    Zhang D, Bergsneider M, Heaney AP, 100th Endocrine Society, Chicago, IL, 1/1/2018
  • Development of a highly sensitive and inexpensive cell-based homeogenous ACTH assay.
    Zhang D, Kelly K, Heaney AP, 100th Endocrine Society, Chicago, IL, 1/1/2018
  • Join now to see all

Lectures

  • Clinical Pearls from Pituitary Disease Case Reports 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Guided Presidential Posters: Neuroendocrinology and Pituitary 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Pituitary Tumors and GHRH, GH, and IGF Biology and Signaling 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Join now to see all

Press Mentions

  • Stress Really Can Cause Weight Gain — and It's Not About Eating
    Stress Really Can Cause Weight Gain — and It's Not About EatingApril 3rd, 2018
  • 7 Sneaky Causes of Weight Gain
    7 Sneaky Causes of Weight GainJune 30th, 2015
  • How to Stay off the Liver Transplant List
    How to Stay off the Liver Transplant ListAugust 30th, 2017
  • Join now to see all

Grant Support

  • Refined Fructose Promotes Pancreatic Cancer GrowthNational Cancer Institute2007–2011
  • Rosiglitazone Treatment In Patients With Cushings Diseaserosiglitazone TreatNational Center For Research Resources2008
  • Rosialitazone: Novel Therapy For Pituitary Tumors (Phas*Food And Drug Administration2007
  • Rosialitazone: Novel Therapy For Pituitary Tumors (Phas*Food And Drug Administration2006
  • Chemoprevention Of Pituitary Corticotroph TumorsNational Cancer Institute2005–2006

Professional Memberships